Vimarsana
Biggest News Aggregation in the World

Page 2 - Biosolution Baltimore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosolution Baltimore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosolution Baltimore Today - Breaking & Trending Today

Report: US cancels deal with vaccine manufacturer - Vimarsana News

Report: US cancels deal with vaccine manufacturer

Earlier this year, doses of the Johnson & Johnson COVID vaccine were ruined at Emergent BioSolutions' Baltimore facility.

Source: wtol.com
Johnson & Johnson vaccine coming to Canada soon: Tam - Vimarsana News

Johnson & Johnson vaccine coming to Canada soon: Tam

Eight months after the vaccine was first authorized by Health Canada, usable doses of the Johnson & Johnson single-shot COVID-19 vaccine are set to arrive and be distributed 'imminently,' according to Chief Public Health Officer Dr. Theresa Tam.

Source: ctvnews.ca
Report: US cancels deal with vaccine manufacturer - Vimarsana News

Report: US cancels deal with vaccine manufacturer

Earlier this year, doses of the Johnson & Johnson COVID vaccine were ruined at Emergent BioSolutions' Baltimore facility.

Source: wtsp.com
Health Canada not releasing more than 300k doses of J&J vaccine over possible quality control issue - Vimarsana News

Health Canada not releasing more than 300k doses of J&J vaccine over possible quality control issue

Health Canada says it 'will not be releasing' the more than 300,000 Johnson & Johnson COVID-19 vaccine doses that arrived in the country in April due to a possible quality control issue.

Source: ctvnews.ca
FDA to authorize two batches of Johnson & Johnson COVID vaccine made at troubled Baltimore plant; others likely to be tossed - Vimarsana News

FDA to authorize two batches of Johnson & Johnson COVID vaccine made at troubled Baltimore plant; others likely to be tossed

Federal regulators at the U.S. Food and Drug Administration will authorize for use two batches of Johnson & Johnson’s COVID-19 vaccine manufactured at the troubled Baltimore facility where critical production errors rendered millions of doses unusable earlier this year.